CTI BioPharma Corp
CTIC
Common Stock
$9.09
Sector: Health Care
Industry: Biotechnology
Sub-Industry: Biotechnology
|
|
|
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.81 | -$1.09 | -$0.74 | -$0.69 | -$0.52 |
Sales/Revenue | $53.95 M | $0.00 M | $0.00 M | $3.35 M | $26.29 M |
Sales Growth | 0.00% | 0.00% | 0.00% | -87.28% | 0.00% |
Gross Margin | +93.12 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$92.99 M | -$97.91 M | -$52.45 M | -$40.02 M | -$29.32 M |
Net Income Growth | 5.02% | -86.67% | -31.06% | -36.49% | 0.00% |
Net Margin | -172.37 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$67.55 M | -$94.81 M | -$47.24 M | -$39.37 M | -$31.65 M |
Cost of Goods Sold (incl D&A) | $3.71 M | $0.53 M | $0.53 M | $0.00 M | $0.88 M |
Cost of Goods Sold (excl D&A) | $1.76 M | $0.00 M | $0.00 M | $0.00 M | $0.29 M |
Cost of Goods Growth | 606.08% | -1.13% | 0.00% | 0.00% | 0.00% |
Research & Development | $36.70 M | $38.61 M | $25.41 M | $24.11 M | $36.47 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $17.63 M | $18.61 M | $21.18 M |
Interest Expense | $14.82 M | $2.45 M | $1.03 M | $1.52 M | $1.73 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.14 | -$0.13 | -$0.21 | -$0.37 |
Sales/Revenue | $21.08 M | $18.24 M | $12.33 M | $2.30 M |
Sales Growth | 15.58% | 47.95% | 437.21% | 0.00% |
Gross Margin | +93.12 | 0.00 | 0.00 | 0.00 |
Net Income | -$17.46 M | -$15.71 M | -$22.65 M | -$37.18 M |
Net Income Growth | -11.16% | 30.67% | 39.06% | -1.05% |
Net Margin | -172.37 | 0.00 | 0.00 | 0.00 |
EBITDA | -$13.06 M | $0.00 M | -$18.31 M | -$24.46 M |
Cost of Goods Sold (incl D&A) | $1.17 M | $1.15 M | $1.49 M | $0.60 M |
Cost of Goods Sold (excl D&A) | $0.64 M | $1.15 M | $0.92 M | $0.28 M |
Cost of Goods Growth | 1.30% | -22.53% | 149.92% | 354.20% |
Research & Development | $11.92 M | $8.22 M | $8.14 M | $7.73 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Interest Expense | $4.77 M | $3.56 M | $3.97 M | $2.08 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $2.08 M | $3.29 M | $2.87 M | $4.61 M | $1.79 M |
Cash and Short-Term Investment | $79.94 M | $65.45 M | $52.45 M | $33.67 M | $67.04 M |
Cash and Short-Term Investment Growth | 22.14% | 24.78% | 55.80% | -49.78% | 0.00% |
Long Term Debt | $62.37 M | $2.02 M | $0.80 M | $7.45 M | $9.27 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $125.93 M | $72.43 M | $58.24 M | $46.28 M | $89.83 M |
Total Assets Growth | 73.85% | 24.37% | 25.84% | -48.48% | 0.00% |
Inventories | $0.73 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Finished Goods | $0.08 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $59.02 M | $48.54 M | $6.65 M | $6.77 M | $4.81 M |
Total Liabilities | $143.50 M | $68.67 M | $18.21 M | $28.35 M | $36.89 M |
2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $2.08 M | $0.00 M | $2.36 M | $2.83 M | $3.29 M |
Cash and Short-Term Investment | $79.94 M | $81.64 M | $95.87 M | $96.90 M | $65.45 M |
Cash and Short-Term Investment Growth | -2.08% | -14.84% | -1.06% | 48.06% | 0.00% |
Long Term Debt | $62.37 M | $47.80 M | $107.38 M | $58.59 M | $2.02 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $125.93 M | $123.47 M | $134.53 M | $131.44 M | $72.43 M |
Total Assets Growth | 1.99% | -8.23% | 2.36% | 81.45% | 0.00% |
Inventories | $0.73 M | $0.00 M | $0.70 M | $0.10 M | $0.00 M |
Finished Goods | $0.08 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $59.02 M | $0.00 M | $0.00 M | $48.34 M | $48.54 M |
Total Liabilities | $143.50 M | $0.00 M | $139.81 M | $159.35 M | $68.67 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|
Quarter | Amount | Yield |
---|
|
|